CRLBF - It's A Matter Of When: Cresco Labs CEO Forecasts Cannabis Rescheduling And Industry Reform | Benzinga
At the Benzinga Cannabis Capital Conference in Florida, Cresco Labs' (OTCQX: CRLBF) CEO Charlie Bachtell shared optimistic views on cannabis rescheduling, emphasizing the importance of the process it's undergoing.
"This is going through the process it needs to... it's a matter of when," Bachtell highlighted, underscoring the significance of Health and Human Services' acknowledgment of cannabis' medicinal value—a monumental step for the industry.
The Political Landscape And SAFER Banking
With a presidential election on the horizon, Bachtell discussed the political implications of rescheduling cannabis. He noted the unlikelihood of a new administration reversing ...